Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
Status: | Completed |
---|---|
Conditions: | Cognitive Studies, Neurology, Psychiatric, Psychiatric |
Therapuetic Areas: | Neurology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 6 - 17 |
Updated: | 4/6/2019 |
Start Date: | June 5, 1985 |
End Date: | May 15, 2017 |
Biological Markers in Childhood Psychiatric Disorders
The purpose of this study is to evaluate individuals with Attention Deficit/Hyperactivity
Disorder (ADHD) to learn more about the genetics of the disease.
This study is part of other ongoing studies of individuals with ADHD. The study participants
have already undergone neurobiological measurements, particularly magnetic resonance imaging
(MRI) of the brain, through other research studies. As a follow-up to these studies,
participants will next undergo psychiatric interviews, neuropsychological tests, and another
MRI. In addition to the clinical evaluation of the participants, further research will be
conducted on the genetics of ADHD. These genetic studies will evaluate people with ADHD as
well as their family members and a control group of healthy people.
Disorder (ADHD) to learn more about the genetics of the disease.
This study is part of other ongoing studies of individuals with ADHD. The study participants
have already undergone neurobiological measurements, particularly magnetic resonance imaging
(MRI) of the brain, through other research studies. As a follow-up to these studies,
participants will next undergo psychiatric interviews, neuropsychological tests, and another
MRI. In addition to the clinical evaluation of the participants, further research will be
conducted on the genetics of ADHD. These genetic studies will evaluate people with ADHD as
well as their family members and a control group of healthy people.
This protocol allows the continuing prospective longitudinal study of ADHD probands for whom
we have neurobiological measures, particularly quantitative brain MRI. The follow-up consists
of structured psychiatric interviews, and neuropsychological tests. Repeat MRI scans are
obtained through protocol 89-M-0006.
The second purpose of this protocol is a study of the genetics of
Attention-Deficit/Hyperactivity Disorder (ADHD). Subjects who have ADHD, their family
members, and controls are studied under this protocol.
we have neurobiological measures, particularly quantitative brain MRI. The follow-up consists
of structured psychiatric interviews, and neuropsychological tests. Repeat MRI scans are
obtained through protocol 89-M-0006.
The second purpose of this protocol is a study of the genetics of
Attention-Deficit/Hyperactivity Disorder (ADHD). Subjects who have ADHD, their family
members, and controls are studied under this protocol.
- INCLUSION REQUIREMENTS-PROBANDS:
Current age of index probands: 15.21 plus or minus 3.42; previous participation in the NIMH
Child Psychiatry Branch ADHD study.
Age adjusted dimensional ratings (Conners Rating Scales-Revised, and Strengths and
Weaknesses of ADHD and Normal Behavior (SWAN)) of hyperactivity/impulsivity greater than or
equal to 95th percentile for index and second sibling. Primary ratings for the index
proband will be provided by main teacher.
Up to 150 ADHD probands for reassessment.
Consent and assent obtained in writing.
EXCLUSION CRITERIA - PROBANDS:
Presence of other known genetic conditions that are likely to be etiologic.
Onset of medical conditions that could produce symptoms of ADHD through non-genetic
mechanisms (e.g., thyroid disorders, seizure disorders, inborn errors of metabolism,
extremely low birth weight (less than 1000 gm), meningitis, intracranial pathology).
Presence of other psychiatric disorders that can produce symptoms similar to ADHD (e.g.,
major depression, bipolar disorder, severe anxiety disorders, pervasive developmental
disorders, psychotic disorders, post-traumatic stress disorder).
Presence of neuropsychiatric conditions that may confound evaluation of ADHD (e.g.,
Tourette's syndrome, obsessive-compulsive disorder, or PANDAS (pediatric autoimmune
neuropsychiatric disorders associated with streptococcus), intelligence quotient less than
80, reading achievement standard scores less than 75 or reading-intelligence discrepancy
greater than 2 SD).
INCLUSION REQUIRMENTS-RELATIVES:
Subjects must be relatives of probands.
Consent and assent obtained in writing.
INCLUSION REQUIREMENTS -NORMAL VOLUNTEERS:
Up to 150 newly accrued normal volunteers unrelated to probands.
Same age range as probands.
Parent and teacher ratings within one SD of population means on ADHD/hyperactivity factors.
Consent and assent obtained in writing.
EXCLUSIONS - NORMAL VOLUNTEERS:
Presence of ADHD.
Presence of any other psychiatric disorders on structured psychiatric interview (DICA-IV).
Presence of known genetic conditions.
Onset, presence or history of medical conditions that could produce symptoms of ADHD
through non-genetic mechanisms (e.g., thyroid disorders, seizure disorders, inborn errors
of metabolism, extremely low birth weight (less than 1000 gm), meningitis, intracranial
pathology).
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Click here to add this to my saved trials